摘要

Authors' objectives: The appraisal aimed to identify and summarise evidence that addresses the following question: what is the clinical and cost effectiveness of N-terminal pro B-type natriuretic peptide (NT-proBNP) or B-type natriuretic peptide (BNP) as a diagnostic test to rule-in and rule-out acute heart failure in adults in the emergency department setting, compared with NT-proBNP, BNP, or standard care to rule-out acute heart failure?